niacinamide has been researched along with chitosan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, GJ; Hugouvieux, V; Klüsener, B; Mori, IC; Murata, Y; Schroeder, JI; Young, JJ | 1 |
| Barthelmes, J; Bernkop-Schnürch, A; Dünnhaupt, S; Friedl, H; Iqbal, J; Perera, G; Thurner, CC | 1 |
| Bernkop-Schnürch, A; Islambulchilar, Z; Laffleur, F; Shahnaz, G | 1 |
| Bao, J; Dai, Z; Lan, Y; Tu, W; Wei, T; Zhao, B | 1 |
| Arora, J; Boonkaew, B; Callaghan, C; Chava, S; Dash, S; He, J; John, VT; Lee, BR; Liu, J; Maddox, MM; Mandava, SH | 1 |
| Chen, Q; Lu, H; Yang, H | 1 |
| Liang, Y; Su, Z; Yao, Y; Zhang, N | 1 |
| Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G | 1 |
| Cao, S; Ruan, W; Wan, T; Wang, Y; Wu, C; Xu, Y; Yu, K; Zhai, Y | 1 |
| Han, HK; Kim, HY; Lee, SH; Song, JG; Zhao, M | 1 |
| Bernkop-Schnürch, A; Gust, R; Jalil, A; Lupo, N; Nazir, I | 1 |
| Abd-Allah, H; Abdel-Aziz, RTA; Nasr, M | 1 |
| Abd El-Hameed, AM; Abd El-Twab, SM; Abdel-Moneim, A; El-Shahawy, AAG; Yousef, AI | 1 |
| Kim, SJ; Lee, JB; Lee, MS; Yoo, HS | 1 |
| Abdel-Moneim, A; El-Shahawy, AAG; Eldin, ZE; Hosni, A; Hussien, M; Zanaty, MI | 1 |
15 other study(ies) available for niacinamide and chitosan
| Article | Year |
|---|---|
Convergence of calcium signaling pathways of pathogenic elicitors and abscisic acid in Arabidopsis guard cells.
Topics: Abscisic Acid; Arabidopsis; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Signaling; Chitin; Chitosan; Cytosol; Fungi; Hydrogen Peroxide; Immunity, Innate; Membrane Potentials; NADP; Niacinamide; Plant Epidermis; Reactive Oxygen Species; Saccharomyces cerevisiae; Signal Transduction | 2002 |
In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan.
Topics: Administration, Oral; Animals; Chitosan; Drug Delivery Systems; Ileum; In Vitro Techniques; Jejunum; Male; Niacinamide; Oligopeptides; Rats; Rats, Sprague-Dawley; Thioglycolates | 2012 |
Design and in vitro evaluation of a novel polymeric excipient for buccal applications.
Topics: Administration, Buccal; Animals; Caco-2 Cells; Cell Survival; Chitin; Chitosan; Drug Carriers; Excipients; Hardness; Humans; Niacinamide; Rhodamine 123; Sulfhydryl Compounds; Swine; Tablets; Water | 2013 |
Electrochemical monitoring of an important biomarker and target protein: VEGFR2 in cell lysates.
Topics: Animals; Biosensing Techniques; Cell Line; Chitosan; Electrochemical Techniques; Endothelial Cells; Graphite; Immunoassay; Macaca mulatta; Niacinamide; Oxidation-Reduction; Phenothiazines; Phenylurea Compounds; Piperidines; Protein Kinase Inhibitors; Quinazolines; Retina; Sorafenib; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Neoplasms; Kinetics; Lactic Acid; Liposomes; Nanoparticles; Nanotechnology; Niacinamide; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Sorafenib; Technology, Pharmaceutical | 2015 |
Chitosan prevents adhesion during rabbit flexor tendon repair via the sirtuin 1 signaling pathway.
Topics: Acetylation; Animals; Apoptosis; Cell Survival; Chitosan; Disease Models, Animal; eIF-2 Kinase; Fibroblasts; Gene Expression Regulation; Humans; Interleukin-1beta; Male; Niacinamide; Primary Cell Culture; Rabbits; Signal Transduction; Sirtuin 1; Tendon Injuries; Tendons; Tissue Adhesions; Tumor Suppressor Protein p53; Wound Healing | 2015 |
pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cations; Cell Proliferation; Chitosan; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Mice; Niacinamide; Phenylurea Compounds; RNA, Small Interfering; Sorafenib | 2015 |
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid | 2017 |
Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Topics: Administration, Cutaneous; Animals; Chitosan; Dermatitis, Atopic; Dinitrochlorobenzene; Drug Delivery Systems; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Niacinamide; Ointments; Rats, Sprague-Dawley; Skin; Skin Absorption; Tacrolimus; Treatment Outcome | 2018 |
Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Survival; Chitosan; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Liposomes; Male; Niacinamide; Phenylurea Compounds; Polymethacrylic Acids; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Sorafenib | 2018 |
In vitro evaluation of intravesical mucoadhesive self-emulsifying drug delivery systems.
Topics: Adhesiveness; Administration, Intravesical; Animals; Cell Survival; Chitosan; Drug Delivery Systems; Emulsions; Mucous Membrane; Mucus; Niacinamide; Sodium Dodecyl Sulfate; Swine; Urinary Bladder | 2019 |
Chitosan nanoparticles making their way to clinical practice: A feasibility study on their topical use for acne treatment.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Chitosan; Drug Carriers; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Male; Nanoparticles; Niacinamide; Particle Size; Polymers; Skin Absorption; Treatment Outcome; Young Adult | 2020 |
Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers.
Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Glucose; Glucosides; Inflammation; Lipid Peroxidation; Liver; Male; Metformin; Nanoparticles; Niacinamide; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Stilbenes; Streptozocin | 2021 |
Clinical evaluation of the brightening effect of chitosan-based cationic liposomes.
Topics: Chitosan; Female; Humans; Liposomes; Melanins; Melanosis; Niacinamide | 2022 |
Therapeutic significance of thymoquinone-loaded chitosan nanoparticles on streptozotocin/nicotinamide-induced diabetic rats: In vitro and in vivo functional analysis.
Topics: Animals; Benzoquinones; Chitosan; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Nanoparticles; Niacinamide; Rats; Streptozocin | 2022 |